Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

T Mary Szela


  • Director at Kura Oncology Inc. (KURA), 2019-06-27
  • Director at Alimera Sciences Inc (ALIM), 2019-06-20
  • Director at Coherus Biosciences Inc. (CHRS), 2019-01-30
  • Chief Executive Officer at Novelion Therapeutics Inc. (NVLN), 2017-05-11
  • Chief Executive Officer at Aegerion Pharmaceuticals Inc. (AEGR), 2016-12-01
  • Director at Receptos Inc. (RCPT), 2015-08-27
  • Senior Vice President at Abbott Laboratories (ABT), 2011-12-16
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ABT $54.46 500 Officer 119,342 2011-12-14 Filing
ABT $54.45 2,781 Officer 119,842 2011-12-14 Filing
ABT $54.44 3,200 Officer 122,623 2011-12-14 Filing
ABT $54.43 2,700 Officer 125,823 2011-12-14 Filing
ABT $54.43 212 Officer 128,523 2011-12-14 Filing